| DB ID | MyCo_4107 |
| Title | Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping |
| Year | 2017 |
| PMID | 28223177 |
| Fungal Diseases involved | Pneumocystis pneumonia |
| Disease | Pneumocystis |
| Associated Medical Condition | inflammatory or autoimmune diseases |
| Genus | Pneumocystis |
| Species | jirovecii |
| Organism | Pneumocystis jirovecii |
| Ethical Statement | The study was approved by the local institutional review board of the participating hospital. Medical charts were reviewed and relevant medical information was extracted by two physicians independently. |
| Site of Infection | Unspecified |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Bronchoalveolar lavage fluid (BALF) |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | CD3+ |
| Biomarker Full Name | CD3+ |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | China |
| Cohort | A total of 123 patients were included in the study. |
| Cohort No. | None |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Chemiluminescence |
| Technique | Immunoassay |
| Analysis Method | Immunological Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunological Assay |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
